Amrize (NYSE:AMRZ) Given New $52.00 Price Target at Oppenheimer

Amrize (NYSE:AMRZ) had its price objective dropped by research analysts at Oppenheimer from $55.00 to $52.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer‘s target price would suggest a potential upside of 20.15% from the stock’s current price.

A number of other analysts have also weighed in on AMRZ. Stephens lowered their target price on Amrize from $65.00 to $54.00 and set an “overweight” rating for the company in a report on Wednesday, August 12th. Deutsche Bank Aktiengesellschaft cut their price target on Amrize from $64.00 to $56.00 and set a “buy” rating on the stock in a report on Wednesday, September 23rd. Bank of America lowered Amrize from a “neutral” rating to an “underperform” rating and reduced their price target for the stock from $50.00 to $40.00 in a research report on Wednesday, September 2nd. DA Davidson upped their price objective on Amrize from $40.00 to $43.00 and gave the stock a “neutral” rating in a research note on Friday. Finally, Barclays dropped their price objective on Amrize from $55.00 to $40.00 and set an “equal weight” rating on the stock in a research report on Monday, October 19th. Eight research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $49.06.

Amrize Stock Up 4.6%

Shares of NYSE:AMRZ traded up $1.90 during trading hours on Monday, hitting $43.28. The company’s stock had a trading volume of 1,449,939 shares, compared to its average volume of 3,434,809. Amrize has a 52 week low of $35.78 and a 52 week high of $65.94. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.67. The company has a market capitalization of $23.94 billion, a price-to-earnings ratio of 19.56, a P/E/G ratio of 1.55 and a beta of 0.20. The firm’s fifty day moving average price is $39.73 and its 200 day moving average price is $50.59.

Amrize (NYSE:AMRZ) last released its quarterly earnings data on Wednesday, October 28th. The company reported $1.05 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.05. The firm had revenue of $3.77 billion for the quarter. Amrize had a net margin of 9.93% and a return on equity of 10.02%. Amrize’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.98 earnings per share. As a group, research analysts expect that Amrize will post 2.41 EPS for the current year.

Insider Activity at Amrize

In other news, CEO Jan Jenisch bought 4,000 shares of the stock in a transaction on Wednesday, September 2nd. The stock was bought at an average cost of $42.50 per share, for a total transaction of $170,000.00. Following the completion of the purchase, the chief executive officer directly owned 519,000 shares in the company, valued at approximately $22,057,500. The trade was a 0.78% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Mario Gross purchased 3,568 shares of the business’s stock in a transaction on Tuesday, August 11th. The stock was purchased at an average cost of $46.60 per share, for a total transaction of $166,268.80. Following the completion of the acquisition, the insider directly owned 38,485 shares of the company’s stock, valued at approximately $1,793,401. The trade was a 10.22% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought a total of 48,983 shares of company stock valued at $2,158,755 over the last three months. Company insiders own 0.54% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in AMRZ. Caldwell Sutter Capital Inc. raised its stake in Amrize by 11.5% in the first quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company’s stock valued at $150,000 after buying an additional 275 shares during the last quarter. Grove Bank & Trust grew its stake in shares of Amrize by 2.1% during the third quarter. Grove Bank & Trust now owns 17,477 shares of the company’s stock worth $653,000 after acquiring an additional 353 shares during the last quarter. Norman Fields Gottscho Capital Management LLC increased its holdings in shares of Amrize by 4.3% during the second quarter. Norman Fields Gottscho Capital Management LLC now owns 11,515 shares of the company’s stock valued at $614,000 after acquiring an additional 475 shares in the last quarter. Farther Finance Advisors LLC increased its holdings in shares of Amrize by 3.9% during the third quarter. Farther Finance Advisors LLC now owns 14,506 shares of the company’s stock valued at $542,000 after acquiring an additional 543 shares in the last quarter. Finally, Choreo LLC raised its position in shares of Amrize by 4.2% in the 3rd quarter. Choreo LLC now owns 17,713 shares of the company’s stock valued at $662,000 after purchasing an additional 706 shares during the last quarter.

About Amrize

Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.

Amrize was formed through the separation of Holcim’s North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.